Marta M. A.
- Country
- Spain
- Department
- Infectious diseases service
Research Overview
- Evaluation of the Impact of a Broadly Neutralizing Antibody and Attachment Inhibitor on Viral Reservoirs in HIV Patients on Integrase Inhibitor-Based Antiretroviral Therapy
- Phase 3 Randomized Open‑Label Study of Switching to Lenacapavir Combined with Teropavimab and Zinlirvimab in Virologically Suppressed Adults with HIV‑1
- Evaluation of High-Dose Rifampicin, Moxifloxacin, and Linezolid Regimen in Bacilliferous Pulmonary Tuberculosis: A Randomized Controlled Trial
Data & Insights
Has run more than one trial at 44 of 94 partner sites.
Specializations
Infectious Disease Research
Specializes in investigating novel treatments for Neisseria gonorrhoeae, focusing on vaccine development and preventive medicine approaches for sexually transmitted infections.
- Bacterial infection prevention
- Vaccine immunogenicity
- Preventive medicine
Particular emphasis on evaluating vaccine safety and efficacy in adult populations.
Tuberculosis Treatment
Conducts research on advanced therapeutic approaches for bacilliferous pulmonary tuberculosis, with expertise in investigating combination drug therapies.
- Multi-drug resistant tuberculosis
- Antibiotic optimization
- Pulmonary infections
Focuses on innovative drug combinations including high-dose antibiotics for enhanced treatment efficacy.
HIV Treatment Innovation
Leads investigations into novel therapeutic approaches for HIV-1 infections, particularly focusing on treatment-naïve adult populations.
- Antiviral therapy
- Treatment-naïve patients
- Viral load management
Specializes in evaluating new antiviral compounds for HIV treatment.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.